MedTrace Logo

The China National COPD Screening Program

NCT05480176 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800000

Last updated 2022-07-29

No results posted yet for this study

Summary

The national COPD screening program is in a cross-sectional manner at the baseline, planning to recruit a total of 800,000 participants from 160 districts or counties (5,000 for each site on average) from 31 provinces, autonomous regions or municipalities directly under the central government of China. The filtered COPD high-risk population and confirmed COPD patients will be managed and followed up according to the standardized clinical guidelines. The major aims of the program are to estimate the prevalences of COPD high-risk population and under- or miss- diagnosed COPD patients, and to manage the development and outcomes of the disease.

Conditions

Interventions

OTHER

Comprehensive intervention and management Ⅰ

Mainly health advisory.

OTHER

Comprehensive intervention and management Ⅱ

Health advisory and regular follow-ups.

OTHER

Comprehensive intervention and management Ⅲ

Pharmaceutical and non-pharmaceutical (e.g. health advisory, rehabilitation, etc.) interventions according to standardized clinical guidelines, with regular follow-ups.

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    lead OTHER

Principal Investigators

  • Ting YANG, M.D. · China-Japan Friendship Hospital

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-09
Primary Completion
2022-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05480176 on ClinicalTrials.gov